Therapy Areas: Diabetes
Insulet receives CE Mark approval for Omnipod 5 Automated Insulin Delivery System
20 September 2022 - Insulet Corporation (NASDAQ: PODD), a provider of tubeless insulin pump technology with its Omnipod brand of products, reported on Tuesday that its Omnipod 5 Automated Insulin Deli...
Oramed Pharmaceuticals reveals positive phase two outcomes from multicentre trial to assess ORMD-0801
14 September 2022 - Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP), a clinical-stage pharmaceutical company, announced on Tuesday positive phase two outcomes from its double-blind, fully rand...
Bayer's Kerendia Receives Updated Label to Include Findings from Phase III FIGARO-DKD Cardiovascular Outcomes Study in Patients with Chronic Kidney Disease and Type 2 Diabetes
2 September 2022 - - German healthcare company Bayer has received approval from the United States Food and Drug Administration for an update to the label for Kerendia (finerenone), a first-in-class no...
Common and Affordable Drug Can Drastically Reduce COVID Complications, Study Shows
31 August 2022 - - The widely available diabetes drug metformin reduced serious COVID outcomes by more than half if started within 4 days of symptoms, in a large, double-blind, randomized, controlled ...
European Commission Approves Biosimilar Ranivisio for Treatment for All Five Lucentis Indications
30 August 2022 - - The European Commission has granted a Marketing Authorization for Ranivisio (ranibizumab), a biosimilar of the ophthalmology treatment Lucentis across all five indications in adults...
Daiichi Sankyo Europe Touts New Lixiana Data in Managing Complex Patient Populations with Atrial Fibrillation
30 August 2022 - - New edoxaban data being presented at The European Society of Cardiology Congress 2022, Japanese pharmaceutical company Daiichi Sankyo's (OTC: DSNKY) Daiichi Sankyo Europe busin...
Related Headlines

KalVista Pharmaceuticals Starts KONFIDENT-S Open Label Extension Study for Sebetralstat in Hereditary Angioedema

Insulet Receives FDA Clearance of Omnipod 5 for Children Aged Two Years and Older with Type 1 Diabetes

City of Hope-Developed Blood Test May Screen for Early-onset Colorectal Cancer

Innovent Biologics doses first diabetic macular oedema patient in phase one IBI324 study

Kodiak Sciences completes enrolment of patients in GLOW Phase three tarcocimab tedromer clinical trial

Innovent Biologics doses first diabetic macular oedema patient in phase one IBI324 study

LG Chem Enters Final Stage of Clinical Development for New Gout Drug

ImmunAbs Gains US FDA Approval for a Phase 1 Clinical Trial

First Patient Dosed in a Phase 1 Trial Evaluating a Novel Off-the-Shelf Engineered Natural Killer Cellular Therapy for the Treatment of Non-Small Cell Lung Cancer

Better Therapeutics Completes Pivotal Trial of BT-001 for Type 2 Diabetes and Announces Positive Secondary Endpoint Results Following the Earlier Announcement of Positive Primary Endpoint Results

Vast Data Selected by CeGaT to Accelerate Time-to-Insight for Genetic Data Analytics

Insulet's Omnipod 5 Automated Insulin Delivery System now fully available in US retail pharmacies

Valbiotis completes recruitment for Phase II/III clinical study with TOTUM-63

Patient Achieves HIV and Blood Cancer Remission Three Decades After HIV Diagnosis Following Stem Cell Transplant at California's City of Hope

Oramed's Second Phase 3 Oral Insulin Trial reaches 50% enrolment